Reblozyl 75 MG vials
Ended Awarded
- Contract number
- SPE2DR26FQQ3K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,632
Award facts
- Contract value 100% obligated
- $16,632.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Reblozyl 75 mg vials with a ceiling value of $16,632.14 under firm fixed pricing. This non-set-aside competitive award is scheduled for completion by December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated significant capability in fulfilling Defense Logistics Agency requirements across multiple therapeutic domains. The company's existing IDC with DLA encompasses a broad portfolio of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Reblozyl, a specialty pharmaceutical used in treating certain blood disorders, exemplifies the contractor's role in supplying specialized medical commodities essential to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQQ3K?
SPE2DR26FQQ3K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQQ3K worth?
The government has obligated $16,632 on SPE2DR26FQQ3K.
Is contract SPE2DR26FQQ3K an order under another contract?
Yes. SPE2DR26FQQ3K is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ3K competed?
The extent of competition for SPE2DR26FQQ3K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award